Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Active substance factsheet - Last updated: 28/06/2024
spinosad (ISO); Reaction mass of Spinosyn A: (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-D-erythropyranosyloxy)-9-ethyl-2,3a,5a,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeaca[b]as-indacene-7,15-dione and Spinosyn D: (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyloxy)-13-(4-dimethylamino-2.3.4.6-tetradeoxy-β-D-erythropyranosyloxy)-9-ethy-2,3,3a,5a,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeaca[b]as-indacene-7,15-dione
EC number:
434-300-1
CAS number:
168316-95-8
IUPAC name:
BAS number:
49
Product-type:
PT18
Candidate for substitution:
Yes
Regulatory categorisation:
Review programme substance
Approval/Assessment status:
Approved
-
Renewal in progress
Competent authority evaluation
No related authorised products are available
Evaluating competent authority:
Netherlands
R4BP asset number:
EU-0005395-0000
Legal act:
Start date:
01/11/2012
End date:
30/04/2025
Assessment Report
Study summary
Evaluating competent authority:
-
Assessment outcome:
Successful
Conclusion date:
31/10/2022
Assessment Report
Study summary
Evaluating competent authority:
Netherlands
Assessment outcome:
Successful
Conclusion date:
04/11/2010
Assessment Report
Study summary